Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio
recent articles
Nijmegen, Netherlands – Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a 1,6M € Eurostars grant together with Pathomation and Radboud University Medical Center to accelerate the development...
TOKYO, (April 03, 2023)— Evident Corporation (“Evident”) announced today that it has been acquired by private equity firm Bain Capital Private Equity (“Bain Capital”) from Olympus Corporation (“Olympus”) pursuant to the definitive...
Andy Beck of PathAI: AI will continue to get better over time. Systems are continually improving and will be considerably more advanced looking ahead just five years from now. This expectation of progress gives us in the AI industry optimism...
Leica Biosystems: The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug...
PathAI: Part of Multi-year Partnership Focusing on Drug Development in NASH and Oncology BOSTON, March 30, 2023 /PRNewswire/ -- PathAI, a leading provider of AI-powered pathology, today announced its partnership with GSK...
PathologyWatch will use AWS Cloud solutions to advance technology capable of delivering digital pathology solutions on a global scale. SALT LAKE CITY (PRWEB) MARCH 27, 2023 - PathologyWatch today announced it has been selected to participate...
